The inhibitory effects of intravenous administration of rabbit immunoglobulin G on airway inflammation are dependent upon Fcγ receptor IIb on CD11c+ dendritic cells in a murine model

Clinical and Experimental Immunology

Volumn 162, Issue 2, 2010, Pages 315-324

  Yamamoto, M ^a   Kobayashi, K ^a   Ishikawa, Y ^a   Nakata, K ^a   Funada, Y ^a   Kotani, Y ^a   Masuda, A ^a   Takai, T ^b   Azuma, T ^a   Yoshida, M ^a   Nishimura, Y ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Allergy; Animal models studies mice rats; Asthma; Dendritic cells (myeloid; Fc receptors (FcRs); Monocyte derived); Plasmacytoid

Indexed keywords

CYTOKINE; FC RECEPTOR IIB; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN G; OVALBUMIN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL HYPERPLASIA; CELL THERAPY; CELLULAR IMMUNITY; COCULTURE; DENDRITIC CELL; DRUG EFFECT; DRUG TREATMENT FAILURE; EOSINOPHILIA; EX VIVO STUDY; EXPERIMENTAL MODEL; FEMALE; GOBLET CELL; IMMUNE DEFICIENCY; IMMUNOMODULATION; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; TH2 CELL; TRANSCRIPTION REGULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11C; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFLAMMATION; MICE; MICE, INBRED C57BL; OVALBUMIN; RECEPTORS, IGG; SPECIFIC PATHOGEN-FREE ORGANISMS; TH2 CELLS;

EID: 78649389971     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04243.x     Document Type: Article

References (31)

1. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17:255-81.
2. Djukanovic R, Wilson SJ, Kraft M et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004; 170:583-93.
3. Muller U, Akdis CA, Fricker M et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998; 101:747-54.
4. Haque S, Boyce N, Thien FC, O'Hehir RE, Douglass J. Role of intravenous immunoglobulin in severe steroid-dependent asthma. Intern Med J 2003; 33:341-4.
5. Salmun LM, Barlan I,Wolf HM et al. Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial. J Allergy Clin Immunol 1999; 103:810-15.
6. Kishiyama JL, Valacer D, Cunningham-Rundles C et al. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroiddependent asthma. Clin Immunol 1999; 91:126-33.
7. Landwehr LP, Jeppson JD, Katlan MG et al. Benefits of high-dose i.v. immunoglobulin in patients with severe steroid-dependent asthma. Chest 1998; 114:1349-56.
8. Nimmerjahn F, Ravetch JV. The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med 2007; 204:11-15.
9. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291:484-6.
10. Li N, Zhao M, Hilario-Vargas J et al. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J Clin Invest 2005; 115:3440-50.
11. Sehra S, Pynaert G, Tournoy K et al. Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on Fc gamma R and IFN-gamma. J Immunol 2003; 171:2080-9.
12. Kuipers H, Lambrecht BN. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr Opin Immunol 2004; 16:702-8.
13. Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002; 2:580-92.
14. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 1996; 379:346-9.
15. Hamelmann E, Schwarze J, Takeda K et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997; 156:766-75.
16. Busse PJ, Zhang TF, Srivastava K, Schofield B, Li XM. Effect of ageing on pulmonary inflammation, airway hyperresponsiveness and T and B cell responses in antigen-sensitized and -challenged mice. Clin Exp Allergy 2007; 37:1392-403.
17. Gonzalez-Juarrero M, Orme IM. Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect Immun 2001; 69:1127-33.
18. Inaba K, Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176:1693-702.
19. Wigginton SJ, Furtado PB, Armour KL et al. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb. Clin Exp Allergy 2008; 38:313-19.
20. van Rijt LS, Lambrecht BN. Dendritic cells in asthma: a function beyond sensitization. Clin Exp Allergy 2005; 35:1125-34.
21. van Rijt LS, Jung S, Kleinjan A et al. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005; 201:981-91.
22. Vermaelen K, Pauwels R. Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry:methodology and new insights. Cytometry A 2004; 61:170-77.
23. Kitamura K, Takeda K, Koya T et al. Critical role of the Fc receptor gamma-chain on APCs in the development of allergen-induced airway hyperresponsiveness and inflammation. J Immunol 2007; 178:480-8.
24. Regnault A, Lankar D, Lacabanne V et al. Fcgamma receptormediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 1999; 189:371-80.
25. Dharajiya N, Vaidya SV, Murai H et al. FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma. PLoS ONE 2010; 5:e9337.
26. Kalergis AM, Ravetch JV. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med 2002; 195:1653-9.
27. Prussin C, Griffith DT, Boesel KM, Lin H, Foster B, Casale TB. Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol 2003; 112:1147-54.
28. Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997; 185:885-92.
29. MacLean JA, Sauty A, Luster AD, Drazen JM, De Sanctis GT. Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice. Am J Respir Cell Mol Biol 1999; 20:379-87.
30. Nimmerjahn F, Ravetch JV. Fcgamma receptors: old friends and new family members. Immunity 2006; 24:19-28.
31. Desai DD, Harbers SO, Flores M et al. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J Immunol 2007; 178:6217-26.